Pilot Study of Sequential Hepatic Radioembolization and Systemic Ipilimumab in Patients With Uveal Melanoma Metastatic to Liver
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Ipilimumab (Primary)
- Indications Liver cancer; Uveal melanoma
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 09 Mar 2016 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
- 28 Dec 2012 New trial record